Cardiol Therapeutics Inc.

Address: 2265 Upper Middle Road East Suite 602 Oakville ON L6H 0G5 CA
Phone: +1 289 910-0850
Email: [email protected]

Cardiol Therapeutics Inc is a clinical-stage life sciences company developing therapies for cardiovascular disease (CVD). The lead product, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation being investigated in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for, CVD. The CardiolRx is also being investigated in patients with acute myocarditis, a leading cause of cardiac death in people less than 35 years old.

In The Press

Cardiol Therapeutics Inc. News